Design and Synthesis of Highly Potent and Selective Pharmacological Chaperones for the Treatment of Gaucher's disease
- 28 August 2006
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 7 (9) , 1356-1359
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase InhibitorsAngewandte Chemie, 2005
- Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase InhibitorsAngewandte Chemie International Edition, 2005
- A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorderThe FASEB Journal, 2005
- α-1-C-Alkyl-1-deoxynojirimycin derivatives as potent and selective inhibitors of intestinal isomaltase: remarkable effect of the alkyl chain length on glycosidase inhibitory profileBioorganic & Medicinal Chemistry Letters, 2004
- N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylationBiochemical Journal, 2003
- A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activityTrends in Pharmacological Sciences, 2003
- Chemical Chaperones—A New Concept in Drug ResearchChemBioChem, 2003
- Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycinsBiochemical Journal, 2002
- Characterization of a Mutant α-Galactosidase Gene Product for the Late-Onset Cardiac Form of Fabry DiseaseBiochemical and Biophysical Research Communications, 1993